Life stress and symptoms of anxiety and depression in women after cancer: The mediating effect of stress appraisal and coping

Seib, Charrlotte; Porter-Steele, Janine; Ng, Shu‐Kay; Turner, Jane; McGuire, Amanda; McDonald, Nicole; Balaam, Sarah; Yates, Patsy; McCarthy, Alexandra; Anderson, Debra

doi:10.1002/pon.4728

Cited by 32 publications

(24 citation statements)

References 39 publications

(73 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It has been documented that people suffering from cancer disease, in most cases, experience high level of stress that can provoke negative symptoms such as anxiety, depression or fear. [ 1 , 2 ] In fact, some people may live through it as a traumatic experience that threatens their physical and psychological well-being. [ 3 ] The impact that this will have on them will vary according to the resources that they use.…”

Section: Introductionmentioning

confidence: 99%

Expression of resilience, coping and quality of life in people with cancer

et al. 2020

View full text Add to dashboard Cite

Considering the importance of coping strategies and resilience in adapting to the stress caused by cancer, the objective of this research is to explore which coping strategies are the most used, in order to know whether different groups of levels of resilience and an appropriate coping style are related to a higher quality of life and better adaptation to the disease. There were 74 participants with cancer in this study (79.7% of them were women) ranging in age from 29 to 85 years ( M = 50.9). Different instruments were used to measure the resilience construct (ER-20 items Resilience Scale), coping strategies (Cognitive Emotion Regulation Questionnaire-Short) and quality of life (General Health Questionnaire). People with higher resilience showed higher scores in the use of adaptive strategies, being acceptance and positive revaluation the most frequent ones. Regarding perception of quality of life, people with lower resilience showed statistically significant differences in the dimensions of pain and general health, which were likewise the most common ones for people with lower resilience. A significant association has been demonstrated between resilience and an adaptive coping, which at the same time are positively linked to quality of life of people with cancer. This study provides information about how different groups of resilience levels are related with coping and quality of life in people with cancer. It could be useful information for psychologists in the oncological area who have to take decisions in the clinical context. A practical consequence would involve trying to modify the type of coping, as well as increasing the level of resilience in people with cancer, in order to achieve a better adjustment to the disease.

show abstract

Section: Introductionmentioning

confidence: 99%

Expression of resilience, coping and quality of life in people with cancer

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Many people suffering from cancer disease, experience high levels of emotional distress (including symptoms such as anxiety, stress, depression, etc.) that can affect their level of physical and psychological well-being ( Castelli et al., 2015 ; Seib et al., 2018 ). Given that the disease process can be associated with declines in self-care, there is a need to investigate their level of mental health ( Hoerger et al., 2016 ).…”

Section: Introductionmentioning

confidence: 99%

Role of neuroticism and extraversion in the emotional health of people with cancer

Macía

Gorbeña

Gomez

et al. 2020

Heliyon

View full text Add to dashboard Cite

The impact that cancer disease can have on individuals varies depending, among other things, on their personal characteristics, so it is important to explore aspects such as the personality traits in relation to mental health in people with cancer. The aim of this study was to analyse the relationship between neuroticism, extraversion and mental health in people with cancer. Besides, this study also explored differences in mental health when combining extraversion and neuroticism levels. One hundred and seventy people who had been diagnosed with different types of cancer (breast cancer, lung, colon, gynaecological cancer and others) composed the sample. Almost all of them (92.9%) had received oncological treatment. The GHQ-12 scale was used to assess the mental health and the 60-item NEO Five-Factor Inventory was applied in order to measure neuroticism and extraversion in participants. A hierarchic lineal regression model was conducted. Neuroticism and extraversion did not show any interaction effect, although a partial mediation was observed in relation to mental health outcomes. Given the significant correlation between neuroticism and extraversion with mental health ( r = .59, p < .001; r = −.41, p < .001), both personality traits were combined, resulting in a classification of four different personality profiles ( F (4;165) = 19.85; p < .001). Results in this study have shown that low levels of neuroticism and high levels of extraversion are related to positive health outcomes. They seem to be protective factors with respect to the mental health in people with cancer. The knowledge of the positive effects of these aspects contributes to the comprehension of mental health in the oncological sample, which should be considered in order to design and guide particular therapeutic interventions adapted to each person.

show abstract

“…[16][17][18] Breast cancer status or its treatments can affect physical functioning long after completion of primary cancer treatments. Thus, our aim was to examine the correlation of insomnia symptoms (independent variable) with occurrence of depressive symptoms and fatigue (main outcomes) 21,23 in breast cancer survivors, accounting for covariates such as demographics, 26 tumor characteristics, 27 cancer treatments, [26][27][28][29][30][31][32] comorbidities at cancer diagnosis, 33 physical activity, 26 psychosocial history, [34][35][36] and use of antidepressants or sleep medications. We evaluated these specific covariates because they have been linked with both depressive symptoms and fatigue in cancer survivors in prior studies.…”

Section: Introductionmentioning

confidence: 99%

“…We evaluated these specific covariates because they have been linked with both depressive symptoms and fatigue in cancer survivors in prior studies. [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36] This knowledge can inform clinical management of long-term breast cancer survivors to improve quality of life.…”

Section: Introductionmentioning

confidence: 99%

Insomnia and Susceptibility to Depressive Symptoms and Fatigue in Diverse Breast Cancer Survivors

Haque

Hsu

Avila

et al. 2021

Journal of Women's Health

View full text Add to dashboard Cite

Background: Nearly 40% of breast cancer survivors have insomnia, yet, information how this condition affects their quality of life is lacking. We examined the association between insomnia and depressive symptoms and fatigue in breast cancer survivors. Methods: Participants were recruited from a community health plan. We conducted a cross-sectional analysis to examine the association between current insomnia (using Insomnia Severity Index [ISI]) and current depressive symptoms (using Inventory of Depressive Symptomology [IDS]) and fatigue (using Fatigue Symptom Inventory [FSI]) in 315 breast cancer survivors who did not have major depressive disorder. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using multivariable logistic regression. Results: The cohort included 30% minority women whose median time since breast cancer diagnosis was 6 years. Survivors with current insomnia symptoms (ISI ‡8) had a sixfold greater odds of current depressive symptoms (IDS >14, OR = 5.98, 95% CI: 3.04-11.76), after adjusting for lifetime insomnia history (OR = 2.01, 95% CI: 1.03-3.94) and perceived stress (OR = 6.37, 95% CI: 2.48-16.32). Insomnia symptoms were markedly associated with moderate fatigue (FSI >3, OR = 5.02, 95% CI: 2.66-9.44). Ever use of antidepressants or sleep medications post-breast cancer diagnosis was not associated with lower odds of current depressive symptoms or feeling fatigued in those with insomnia symptoms. Conclusion: Current insomnia symptoms were strongly correlated with current depressive symptoms and fatigue. Survivorship care plans should consider incorporating insomnia screening to that may potentially enhance quality of life domains.

show abstract

Life stress and symptoms of anxiety and depression in women after cancer: The mediating effect of stress appraisal and coping

Cited by 32 publications

References 39 publications

Expression of resilience, coping and quality of life in people with cancer

Expression of resilience, coping and quality of life in people with cancer

Role of neuroticism and extraversion in the emotional health of people with cancer

Insomnia and Susceptibility to Depressive Symptoms and Fatigue in Diverse Breast Cancer Survivors

Contact Info

Product

Resources

About